Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections
About this episode
This episode features an interview discussing the use of Azelastine nasal spray in preventing SARS-CoV-2 infections.
Interview with Robert Bals, MD, PhD, author of Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections: A Phase 2 Randomized Clinical Trial, and Dan H. Barouch, MD, PhD, author of A Novel Approach for Preventing Respiratory Virus Infections. Hosted by Eve Rittenberg, MD. Related Content: Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections A Novel Approach for Preventing Respiratory Virus Infections
More episodes of JAMA Internal Medicine Author Interviews
- Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease
- Wait Time Modifications for Black Kidney Transplant Candidates
- Incidental Rotator Cuff Abnormalities on Magnetic Resonance Imaging
- Primary Care Clinicians Available for New Patient Visits
- Magnesium Supplementation and Tachyarrhythmias
- Lifestyle Intervention for Sustained Remission of Metabolic Syndrome
Explore listener stats, chart rankings, contacts and more on the JAMA Internal Medicine Author Interviews podcast page.